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Edited by Judit Ova´diAbstract Microtubule (MT) dynamic instability is tightly reg-
ulated by stabilizing and destabilizing proteins, the latter being
exempliﬁed by stathmin/Op18, a protein known to destabilize
MTs. Studies in cells have indicated that the level of stathmin
expression modiﬁes the cytotoxicity of antimicrotubule drugs,
such as vinblastine (VLB). Using isothermal titration calorime-
try and analytical ultracentrifugation, we show that VLB in-
creases the aﬃnity of stathmin for tubulin 50-fold (and vice
versa). These results are the ﬁrst biochemical evidence of the di-
rect relationship between stathmin and an antimitotic drug, and
reveal a new mechanism of action for VLB.
Structured summary:
MINT-6603918:
tubulin beta (uniprotkb:Q9H4B7), tubulin alpha (uni-
protkb:Q71U36) and stathmin (uniprotkb:Q71U36) physically
interact (MI:0218) by cosedimentation (MI:0027)
MINT-6603930:
tubulin alpha (uniprotkb:Q71U36) physically interacts
(MI:0218) with tubulin beta (uniprotkb:Q9H4B7) and stathmin
(uniprotkb:P16949) by isothermal titration calorimetry
(MI:0065)
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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The microtubule (MT) cytoskeleton is a dynamic network
that plays a crucial role in many cellular processes, including
cell division. MTs are characterized by their ability to switch
abruptly between growing and shortening. This dynamic
behaviour, called dynamic instability, guarantees cellularAbbreviations: ITC, isothermal titration calorimetry; VLB, vinblastine;
T2S, complex of stathmin with two tubulin dimers; MT, microtubule;
AUC, analytical ultracentrifugation
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doi:10.1016/j.febslet.2008.06.035homeostasis and is tightly regulated by stabilizing and destabi-
lizing MT associated proteins (MAPs). Over the past several
decades, signiﬁcant advancements have been made in our
understanding of the mechanism of action of stabilizing
MAPs, such as Tau [1–4]. More recently, however, attention
has turned to a family of destabilizing molecules: stathmin
and its family members that share the same SLD (stathmin like
domain), such as RB3 [5].
Stathmin is known to promote MT depolymerization by
increasing the catastrophe rate (transition from a state of
growth to a state of shrinkage) and sequestering free tubulin,
thus lowering the pool of ‘‘assembly competent’’ tubulin [6].
A number of reports have shown that stathmin is expressed
at high levels in a wide variety of human cancers [7–10].
Furthermore, it has been observed that stathmin modiﬁes the
antimitotic eﬃciency of antitumor cancer drugs, such as vin-
blastine (VLB) [11,12]. However, despite a variety of data from
cell lines, the molecular basis of this process is not known.
Recent crystallographic data suggest that both VLB and stath-
min might act together, since they can bind simultaneously on
free tubulin and each results in the curving of tubulin dimer ﬁl-
aments [13]. In this study, we present the ﬁrst direct evidence of
the functional synergy between endogenous stathmin and the
antimitotic drug VLB. Using isothermal titration calorimetry
(ITC) and analytical ultracentrifugation (AUC), we demon-
strate that VLB signiﬁcantly increases the stathmin binding
constant for tubulin and that stathmin has the same eﬀect on
the VLB binding constant for tubulin. Stathmin can thus be re-
garded as a novel mediator of cell sensitivity to VLB, thereby
enhancing its potential as a promising target for cancer thera-
peutics.2. Materials and methods
2.1. Materials
All chemicals (Sigma–Aldrich Co., USA) were of the highest grade.
VLB was from Lilly (Suresnes, France). To measure VLB concentra-
tion we used its molar extinction coeﬃcient at 320 nm in phosphate
GTP buﬀer: 4642 M1 cm1 [14].
2.2. Protein puriﬁcations
Tubulin was puriﬁed from lamb brains by ammonium sulfate frac-
tionation and ion-exchange chromatography and stored in liquid
nitrogen as described. Tubulin concentration was determined spectro-
photometrically at 275 nm with an extinction coeﬃcient of
109000 M1 cm1 in 6 M guanidine hydrochloride [1,15]. Human
stathmin was ampliﬁed from a pCR 2.1 vector containing the stathminblished by Elsevier B.V. All rights reserved.
Fig. 1. Distribution of the sedimentation coeﬃcient C(s) of 13 lM
tubulin (green line), 13 lM tubulin with 13 lM stathmin (black line),
13 lM tubulin with 6 lM vinblastine (red line) and 13 lM tubulin with
13 lM stathmin in the presence of 6 lM vinblastine (blue line) at
10 C. All RMSD values were under 0.02.
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was expressed in Escherichia coli BL21(DE3). Stathmin expression was
induced by the addition of 0.4 mM isopropyl 1-thio-D-galactopyrano-
side (IPTG) to cells when A600nm reached 0.6. After 4 h of induction at
37 C, cells were pelleted and resuspended in 20 mM Tris–HCl, 1 mM
EDTA, pH 8 containing an antiprotease cocktail (Roche). After two
runs in the French press (6 tones), the lysate was cleared by centrifuga-
tion (3000 · g, 15 min, 4 C), boiled for 5 min, and centrifuged at
100000 · g for 1 h at 4 C. This supernatant was loaded onto a HiTrap
DEAE-FF column (GE Healthcare) pre-equilibrated with 20 mM
Tris–HCl, pH 8 and then eluted with the same buﬀer with additional
200 mM NaCl. Further puriﬁcation was achieved using a SourceTM
15RPC PE 7.5/150 (GE Healthcare) reverse-phase column equilibrated
with H2O, TFA (0.065%), and eluted with acetonitrile, TFA (0.05%).
Fractions containing stathmin were then pooled and dry-lyophilized.
Stathmin was resuspended and its concentration determined by the
Lowry method with DC Protein Assay (Bio-Rad) and then adjusted,
after ITC experiments, to reach the expected stathmin:tubulin stoichi-
ometry of 0.5 [16].
2.3. ITC
Binding of VLB and stathmin to tubulin was analyzed by ITC using
MicroCal MCS or auto-ITC at 10 C in 20 mM NaPi buﬀer, in the
presence of 0.1 mM GTP, pH 6.5. Experimental temperature was cho-
sen to maximize DH values and to compare our results with previously
published data [16]. Tubulin concentrations in the calorimetric cell ran-
ged from 5 to 20 lM, whereas the ligand (VLB or stathmin) concentra-
tions varied from 50 to 200 lM. Stathmin binding to tubulin was
carried out in the presence or absence of VLB and VLB binding to
tubulin was carried out in the presence or absence of stathmin. The
baseline was measured by injecting the ligand into the protein-free buf-
fer solution. Data were analyzed using the MicroCal Origin software
and were ﬁtted with a ‘‘one set of sites’’ and led to the determination
of aﬃnity constants (K) and enthalpy changes (DH) as previously de-
scribed [17]. Consequently, the entropy variations (DS) were calculated
according to the standard equations. The change in heat capacity of
binding (DCp) was obtained by measuring the change of the binding
enthalpy at 5, 10, 15 and 25 C from the relationship DCp = d(DH)/
dT, assuming that DH approximates a linear function of temperature.
2.4. AUC
Experiments were performed at 40000 rpm and 10 C in a Beckman
Optima XL-A analytical ultracentrifuge equipped with absorbance op-
tics, using an eight hole An50Ti rotor and 1.2 cm Epon double-sector
centerpieces. Apparent sedimentation coeﬃcients were determined by
the sedimentation coeﬃcient distribution C(s) generated by SEDFIT
program [18]. All the AUC experiments were done in 20 mM NaPi,
10 lM GTP, pH 6.5. Tubulin concentration was 13 lM. All samples
for AUC were prepared under the same conditions as for ITC.Fig. 2. Schema of formation of T2S–VLB complex in two diﬀerent
ways: (A) through tubulin/VLB isodesmic indeﬁnite polymer forma-
tion; (B) through intermediate T2S complex.3. Results and discussion
3.1. Oligomeric state of tubulin and its complexes
The oligomeric state of tubulin was monitored by AUC. As
expected, without VLB or stathmin, tubulin sedimented as a
single species centered at an apparent sedimentation coeﬃcient
Sapp of 5.08S (Fig. 1, green curve), which corresponds to the
usual proﬁle for pure tubulin heterodimers with a standard
sedimentation coeﬃcient S20;W of 5.8S [19]. In the presence
of equimolar concentrations of stathmin, these species disap-
peared in favor of the formation of the typical complex of
stathmin with two tubulin dimers (T2S) sedimenting at a Sapp
of 7.7S (Fig. 1, black curve) [20]. Moreover, in the presence of
VLB, a wide distribution with a main peak centered at a Sapp
of 9.7S was observed (Fig. 1, red curve), corresponding to an
equilibrium between tubulin oligomers and several indeﬁnite
isodesmic self-associating tubulin polymers induced by the
binding of VLB [21]. In the presence of stathmin and VLB, this
wide distribution turned into a single peak at 7.4S (Fig. 1, bluecurve), indicating the disassembly of VLB-induced tubulin
oligomers and the subsequent formation of a T2S–VLB com-
plex. The slight, but reproducible, shift of this peak compared
to the T2S one, could suggest that the complex formed in pres-
ence of VLB is more compact or that the binding of VLB in-
duces a rearrangement of charges at the surface of the
complex. The same proﬁle was observed when stathmin was
added to tubulin prior to VLB, showing that, under our con-
ditions, stathmin is not only able to inhibit VLB-induced poly-
mer formation but also to depolymerize it (Fig. 2).
3.2. Thermodynamic parameters of tubulin complex formation
To determine the impact of VLB on the thermodynamic
parameters of the stathmin–tubulin interaction, ITC was used.
A microcalorimetric approach allows the full characterization
of this interaction in solution from a thermodynamic point of
view [16]. We ﬁrst investigated stathmin binding to tubulin in
Table 1
Thermodynamic parameters of VLB and stathmin binding to tubulin and its complex determined by direct ITC measurements at 10 C
Sample Ligand Kapp (M
1) DHapp (kcal mol
1) DSapp (cal mol
1 K1)
B1 Tubulin Stathmin (1.1 ± 0.7) · 107 31.5 ± 7.9 143 ± 26
A2 Tubulin/VLB Stathmin >(1.6 ± 1.0) · 108 23.6 ± 9.6 121 ± 4
A1 Tubulin VLB (5.0 ± 1.6) · 105 16.1 ± 2.3 83 ± 8
B2 T2S VLB (2.5 ± 1.8) · 107 08.2 ± 0.4 63 ± 2
A1, B1, A2 and B2 correspond to the reactions presented in Fig. 2.
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we studied VLB binding to tubulin in absence (Fig. 2, A1) or
presence (Fig. 2, B2) of stathmin. The thermodynamic param-
eters found for the tubulin–stathmin interaction (Table 1) are
in good agreement with the parameters found by Honnappa
et al. under similar experimental conditions [16].
We then monitored the binding of stathmin to the tubulin/
VLB complex (Figs. 2, A2 and 3) and found that VLB in-
creases stathmin aﬃnity to tubulin more than 15-fold (Table
1). This value is very close to the maximum binding constant
that can be reliably measured by ITC for this concentration
of tubulin. Thus, the stathmin–tubulin binding constant in
the presence of VLB could be underestimated. Assuming thatFig. 3. ITC curves of VLB and stathmin interaction with tubulin (red
and black curves, respectively), VLB interaction with T2S (blue curve)
and stathmin binding with tubulin/VLB complex (green line) at 10 C
in 20 mMNaPi buﬀer in the presence of 0.1 mMGTP, pH 6.5. All four
titration curves were obtained during one set of experiments at Auto-
ITC. (A) Titration of tubulin or its complex by the ligand; (B) binding
isotherm derived from (A).stathmin would increase the association constant of VLB to
tubulin in the same way we tried to get a better approximation
of this underestimated constant by measuring the inﬂuence of
stathmin on VLB binding to tubulin.
By following the binding of VLB to tubulin by ITC, we
found thermodynamic parameters (Table 1) in the range of
previously published data [22,23]. In the presence of stathmin,
we observed a 50-fold increase in the VLB–tubulin binding
constant. The fact that VLB increases stathmin binding on
tubulin, and vice versa, is in good agreement with the X-ray
structure of the RB3–tubulin complex which revealed that
both stathmin and VLB binding induce similar conformational
consequences, curving consecutive tubulin dimers [13].
According to our AUC and previously published data [6,24],
VLB and stathmin binding to tubulin are coupled to either
tubulin assembly or disassembly (Figs. 1 and 2). Since the
ITC method registers the integral heat eﬀect from all reactions
in the calorimetric cell, it provides us only with apparent ther-
modynamic parameters. It should be noted that the binding of
VLB to T2S complex (Fig. 2, B2) is not coupled with tubulin
assembly or disassembly and thus all the measured thermody-
namic parameters for this process are not apparent. Neverthe-
less, in spite of assembly/disassembly secondary processes in
A1, A2 and B1 equilibria (Fig. 2), binding isotherms could
be ﬁtted with a simple ‘‘one set of sites’’ model which gave en-
thalpy values that verify the equation:
DH appA1 þ DH appA2 ¼ DH appB1 þ DHB2
This equality, together with AUC data, validate our model
presented in Fig. 2, which suggests that both paths (A and
B) lead to the formation of the same stathmin–tubulin–VLB
complex. One of the consequences of this model is a conserva-
tion of the product between the stathmin binding constant and
the VLB binding constant whichever pathway is taken:
KappA1  KappA2 ¼ KappB1  KB2
This enabled us to recalculate the previously underestimated
KappA2 by direct ITC measurement. We found a value of
5.5 · 108 M1, corresponding to a 50-fold increase in stathmin
aﬃnity to tubulin in the presence of VLB (instead of the 15-
fold estimated above).
It should be noted that at 10 C all observed binding pro-
cesses described here (Table 1) are entropy driven (DS > 0)
and enthalpy unfavorable (DH > 0), indicating that both
VLB and stathmin binding to tubulin lead to burying of
hydrophobic surfaces [25]. At physiological temperature
(37 C) however, DH of VLB–tubulin binding was too small
to be precisely measured, thus the change in the heat capacity
of binding of VLB (DCp = dDH/dT) was determined as de-
scribed in Section 2 (Fig. 4). The DCp values for the analyzed
complexes are negative: 388 ± 32 cal mol1 K1 for VLB
binding to tubulin (Fig. 2, A1) and 1052 ± 56 cal mol1 K1
for VLB binding to T2S (Fig. 2, B2). Since the VLB site on
Fig. 4. Temperature dependence of enthalpy of VLB binding to
tubulin (A1, red curve) and to T2S (B2, blue curve) determined by
direct ITC measurements.
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this diﬀerence in the DCp observed in the two binding processes
(B2 and A1) can be explained by the positive contribution to
DCp from the burying of inter-tubulin interface hydrophobic
surfaces [26] during VLB-induced tubulin oligomerization.
These values of DCp enabled us to calculate DH = 2 kcal mol
1
for VLB binding to tubulin and DH = 20 kcal mol1 for VLB
binding to T2S at 37 C. These data indicate that at the phys-
iological temperature stathmin changes the thermodynamic
mode of VLB binding to tubulin to an enthalpy-driven one,
thus contributing to the observed increase in aﬃnity of VLB
to tubulin.
3.3. Biological signiﬁcance
Overall, our results demonstrate that VLB dramatically in-
creases stathmin aﬃnity for tubulin, and vice versa. We dem-
onstrated the existence of a second mechanism of action for
VLB: not only can it directly bind to MTs and curve protoﬁl-
aments, but it can also favor stathmin binding, thus enhancing
its depolymerizing activity. In addition to being targeted in
new anti-cancer strategies, stathmin is also a new mediator
of VLB activity. This is the ﬁrst report to provide a possible
biophysical explanation for the increased sensitivity to Vinca
alkaloids in cells over-expressing stathmin [12]. This mecha-
nism could contribute to Vinca alkaloid selectivity for tumor
cells in which stathmin is over-expressed compared to normal
cells [7–10].
This in vitro study using recombinant stathmin enabled us to
examine stathmin binding in its non phosphorylated active
form. Nevertheless, we know that during the cell cycle and
other cellular processes stathmin activity is tightly regulated
by phosphorylation, adding an additional level of regulation
and complexity to the stathmin–VLB–tubulin interactions.
We plan to address this regulation in future studies as well
as determine if this eﬀect of stathmin is speciﬁc for VLB or
if other antimitotic drugs can interact with endogenous pro-
teins.
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